Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Reproduction (Cambridge, England). Supplement|September 11, 2002
Effects of GnRH agonist (leuprolide) on reproduction and behaviour in female wapiti (Cervus elaphus nelsoni)D L Baker, M A Wild, M M Conner, et al.
European Radiology|September 26, 2000
Improving postoperative MR imaging of pituitary macroadenomas: comparison of full and reduced dose of gadopentetate dimeglumineJ K Hald, O P Eldevik, R L Dunn, et al.
The International Journal of Periodontics & Restorative Dentistry|February 1, 1995
Initial study of guided tissue regeneration in Class II furcation defects after use of a biodegradable barrierA M Polson, G L Southard, R L Dunn, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2000
Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapyH M Sandler, R L Dunn, P W McLaughlin, et al.
The Journal of Urology|August 8, 2001
Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairmentS Kielb, R L Dunn, M G Rashid, et al.
American Journal of Health Promotion : AJHP|February 24, 2001
The relationship between modifiable health risks and group-level health care expenditures. Health Enhancement Research Organization (HERO) Research CommitteeD R Anderson, R W Whitmer, R Z Goetzel, et al.
American Journal of Public Health|November 14, 1997
A two-step intervention of increase mammography among women aged 65 and olderN K Janz, D Schottenfeld, K M Doerr, et al.
American Journal of Health Promotion : AJHP|February 24, 2001
Projecting future medical care costs using four scenarios of lifestyle risk ratesJ A Leutzinger, R J Ozminkowski, R L Dunn, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2009
Rescoring the NIH chronic prostatitis symptom index: nothing newJ Q Clemens, E A Calhoun, M S Litwin, et al.
Journal of Occupational and Environmental Medicine|November 30, 2000
Gender-specific effects of modifiable health risk factors on coronary heart disease and related expenditures. HERO Research Committee. Health Enhancement Research OrganizationJ Wasserman, R W Whitmer, T L Bazzarre, et al.
Pageof 7